Related Experiment Video
Updated: May 25, 2026

Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
Platelet function after cessation of chronic clopidogrel therapy.
Peter G Perakis1, Tahir Yunus, Graham Long
1Department of Surgery, Beaumont Health System, Royal Oak, Michigan 48073, USA. pperaki1@hfhs.org
Discontinuing clopidogrel before surgery allows platelet function to recover over 4 days. Individual monitoring of platelet function aids surgeons in managing patients on clopidogrel therapy undergoing elective procedures.
Area of Science:
- Cardiology
- Pharmacology
- Surgical Management
Background:
- Clopidogrel is frequently used in patients requiring surgery.
- Managing clopidogrel therapy perioperatively presents clinical challenges.
Purpose of the Study:
- To evaluate platelet function changes after clopidogrel discontinuation in patients undergoing elective surgery.
- To determine the time course of platelet function recovery post-clopidogrel cessation.
Main Methods:
- Prospective study of patients on chronic clopidogrel therapy scheduled for elective surgery.
- Platelet function assessed using VerifyNow P2Y12 device at baseline and every other day before surgery.
- Analysis of platelet inhibition levels and P2Y12 reaction units.
Main Results:
- Mean platelet inhibition decreased from 32.1% at baseline to 3.7% by Day 4 after clopidogrel discontinuation.
- Significant time-dependent decrease in platelet inhibition (P=0.011) was observed.
- Considerable interindividual variability in P2Y12 reaction units and decreased clopidogrel effect noted with proton pump inhibitor co-administration.
Conclusions:
- Platelet function significantly recovers within a week of clopidogrel discontinuation.
- Individual platelet function monitoring can guide perioperative decisions for patients on clopidogrel.
- Further research into factors influencing clopidogrel's antiplatelet effect is warranted.
More Related Videos
04:37Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
05:49Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
Published on: November 29, 2024
Related Concept Videos
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Clot Retraction and Fibrinolysis
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Anticoagulant Drugs: Low-Molecular-Weight Heparins